KPTI | Karyopharm Therapeutics (NASDAQ:KPTI) Lifted to Sell at BidaskClub

Karyopharm Therapeutics (NASDAQ:KPTI) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Tuesday, BidAskClub reports.Several other research analysts have also issued reports on the company.SVB Leerink lowered their target price on Karyopharm Therapeutics from $31.00 to $30.00 and set an […]Daily Political